Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 386 posts found.

merck_and_co

MSD and Pfizer receive approval for combo diabetes therapy

December 21, 2017
Sales and Marketing MSD, Pfizer, biotech, diabetes, drugs, pharma, pharmaceutical

MSD (known as Merck in North America) and Pfizer have announced that their sodium-glucose co-transporter 2 (SGLT2) inhibitor has received …

News
shutterstock_138095450

Novartis, Abbott targeted by Indian watchdog over allegations of price collusion

December 14, 2017
Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin

Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …

News
fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017
Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …

News
diabetes-2424105_960_720

Study reveals diet able to reverse diabetes in half of patients

December 6, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% …

News
novo_flag

Novo Nordisk unveils hard-hitting data for two of its diabetes therapies

December 5, 2017
Manufacturing and Production, Research and Development Novo Nordisk, Tresiba, Xultophy, diabetes, pharma

Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …

News
diabetes-2424105_960_720

Type 1 diabetes misunderstood as “disease of childhood”

December 1, 2017
Medical Communications biotech, diabetes, drugs, pharma, pharmaceutical

New research published in The Lancet has revealed that type 1 diabetes cannot be understood as a “disease of the …

News

Psoriasis patients at greater risk of type 2 diabetes, study reveals

November 15, 2017
Research and Development diabetes, pharma, psoriasis, type 2 diabetes

Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk …

News

Sanofi Q3 results disappoint due to waning diabetes sales

November 2, 2017
Sales and Marketing Lantus, Sanofi, diabetes, pharma

Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net …

News

Sanofi launches patent infringement lawsuit against Mylan over diabetes pen

October 25, 2017
Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …

News
diabetes-2424105_960_720

Type 3 diabetes more common than Type 1 and often misdiagnosed

October 25, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …

News

Novo’s diabetes treatment semaglutide gets unanimous FDA backing

October 19, 2017
Sales and Marketing Novo Nordisk, diabetes, semaglutide

Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one …

News
diabetes-777001_960_720

Sanofi plans summit to tackle diabetes in 5 million Nigerian citizens

October 17, 2017
Manufacturing and Production, Medical Communications Nigeria, Sanofi, WHO, diabetes, pharma

Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million …

News
jj

J&J exits insulin pump business, rival looks to scoop patients

October 10, 2017
Manufacturing and Production Johnson & Johnson, biotech, diabetes, drugs, pharma, pharmaceutical

Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …

News

Sanofi promotes global head of diabetes to expand role

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

Appointment

Novo’s Xultophy beats basal insulin in cutting cardiovascular risk

September 14, 2017
Research and Development Novo Nordisk, Xultophy, diabetes, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has unveiled new data on its diabetes treatment Xultophy (insulin degludec/liraglutide) which supports its efficacy in reducing risk …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024